How to Manage High Cholesterol in India

High cholesterol has no symptoms. The first sign in many people is a heart attack or stroke — which is why millions of Indians carry elevated LDL for years without realising it. A standard lipid profile costs Rs 300–600 at any diagnostic lab, requires a 12-hour fast, and delivers a result in half a day. If you have not had one in the past two years — or if you have already received a high report and are unsure what to do next — this guide covers what the numbers mean, what actually lowers them, and when medication becomes unavoidable.

Reading your lipid profile: the four numbers that matter

A standard lipid profile measures four values. Most people focus on total cholesterol alone, which is the least useful number on its own. What your doctor actually looks at:

• LDL (Low-Density Lipoprotein): The primary target of treatment. LDL particles deposit cholesterol in artery walls, contributing to plaques. For most adults without other risk factors, the target is below 100 mg/dL. For people with diabetes, prior heart disease, or high blood pressure, the target tightens to below 70 mg/dL.
• HDL (High-Density Lipoprotein): The protective kind. HDL ferries excess cholesterol back to the liver for disposal. In Indians, HDL tends to run low — below 40 mg/dL in men and 50 mg/dL in women is considered a risk factor. Higher is better; above 60 mg/dL is cardioprotective.
• Triglycerides: Fat molecules that rise with refined carbohydrates, alcohol, and uncontrolled diabetes. Target: below 150 mg/dL. Levels above 500 mg/dL carry an independent risk of pancreatitis.
• Total Cholesterol: The sum of LDL, HDL, VLDL, and other fractions. Useful only as context — a high total driven by high HDL is far less concerning than the same total driven by high LDL. Do not panic based on total cholesterol alone.
• Non-HDL Cholesterol: Total cholesterol minus HDL. Increasingly used because it captures all atherogenic particles, not just LDL. Target: below 130 mg/dL for most adults.

Why your risk score matters more than one lab number

Cholesterol is not treated in isolation. Before deciding whether medication is warranted, your doctor should calculate your 10-year cardiovascular risk using a scoring tool (such as the ACC/AHA Pooled Cohort Equations or the Indian-adapted QRISK). This pulls in your age, sex, blood pressure, smoking status, diabetes, and HDL alongside LDL to estimate your actual probability of a heart attack or stroke in the next decade. A 45-year-old non-smoker with LDL of 140 and no other risk factors has a very different profile from a 55-year-old with diabetes, hypertension, and the same LDL number — and the treatment approach differs accordingly.

• Low risk (under 7.5% 10-year risk): Lifestyle changes first; medication generally deferred for 3–6 months unless LDL is very high.
• Intermediate risk (7.5–20%): Shared decision-making between doctor and patient — some will benefit significantly from statins even if LDL is borderline.
• High risk (over 20%, or diabetes, or prior cardiovascular event): Medication is strongly recommended alongside lifestyle intervention, with LDL target of under 70 mg/dL.

Diet changes that move the needle — in an Indian context

Dietary change alone typically lowers LDL by 10–25%, which is enough to avoid medication for many people in the low-to-intermediate risk category. The changes that have the clearest evidence:

• Replace saturated fat with unsaturated fat. Saturated fats (found in ghee, butter, full-fat dairy, coconut oil, and red meat) raise LDL by increasing cholesterol synthesis in the liver. Switching to mustard oil, groundnut oil, or olive oil for daily cooking is one of the highest-impact changes an Indian household can make. This is not about eliminating ghee entirely — a teaspoon occasionally is fine. It is about replacing it as the primary cooking medium.
• Increase soluble fibre. Soluble fibre binds cholesterol in the gut and removes it before it enters the bloodstream. Best sources in the Indian diet: oats (daliya or oat porridge at breakfast), whole lentils and legumes (chana, rajma, moong, masoor dal), isabgol (psyllium husk) added to water before meals, fruits with skin (apple, pear, guava), and fenugreek seeds (methi). Aim for 10–25 g of soluble fibre daily.
• Cut refined carbohydrates and sugar. White rice (especially in large portions), maida-based breads, biscuits, namkeen, and sugary drinks drive up triglycerides and lower HDL. Switching to smaller portions of rice, substituting with millets (jowar, bajra, ragi), and eliminating packaged snacks is more impactful for Indian lipid profiles than reducing dietary cholesterol from eggs.
• Add plant sterols. Found in some fortified margarines and in smaller amounts in nuts, legumes, and whole grains, plant sterols block cholesterol absorption. Some cardiac-specific functional foods marketed in India contain added sterols — they are a genuine adjunct, not a gimmick, though the effect is modest (5–10% LDL reduction).
• Rethink eggs. Dietary cholesterol from eggs has less impact on blood cholesterol than saturated fat. For most people, 1 egg per day is fine. The bigger concern in a typical Indian breakfast is the butter or oil used alongside it.

Exercise: how much and what kind

Exercise has a more reliable effect on HDL and triglycerides than on LDL, but it contributes meaningfully to overall cardiovascular risk reduction:

1. Aerobic exercise (150 minutes per week at moderate intensity): Brisk walking, cycling, swimming, or dancing. This is the minimum — split across 5 days of 30 minutes each. In urban India, a morning walk of 5–6 km at a pace where you are slightly breathless but can still hold a conversation meets this target.
2. Resistance training (2 sessions per week): Bodyweight exercises, gym work, or yoga. Improves insulin sensitivity, which in turn reduces triglycerides and raises HDL.
3. Reduce prolonged sitting. Desk workers who walk 150 minutes weekly but sit for 10+ hours daily still face elevated cardiovascular risk. Breaking sedentary time with a 5-minute walk every hour adds independent benefit.

When statins are prescribed — and are they safe?

Statins (atorvastatin, rosuvastatin — available as Atorva, Rosuvas, and many generics at Rs 5–20 per tablet in India) are the most studied drugs in cardiovascular medicine. They lower LDL by 30–50% depending on dose, reduce heart attack risk by approximately 25–35% in high-risk patients, and have a safety record spanning 30+ years of use. For people who need them, there is very little to weigh against starting.

• The muscle pain myth: Statin-related myopathy (true muscle damage) occurs in roughly 1 in 10,000 patients. Mild muscle aches without elevated CK enzyme levels are common in the first weeks and usually resolve. If muscle pain is severe or accompanied by dark urine, stop the statin and call your doctor immediately.
• Liver safety: Statins mildly raise liver enzymes in a small number of patients. Routine liver monitoring after starting a statin is no longer recommended in most guidelines unless symptoms arise. People with pre-existing liver disease should discuss alternatives.
• Diabetes risk: High-dose statins carry a small increased risk of new-onset diabetes (~10–12% relative risk increase). For people already at high cardiovascular risk, this trade-off is clearly worthwhile — the absolute reduction in heart attacks exceeds the diabetes risk.
• Statins are not a substitute for lifestyle change. Combining a statin with dietary improvement produces significantly better LDL reduction than either intervention alone, and lifestyle change addresses HDL and triglycerides that statins do not fully correct.

How often to retest

The monitoring schedule depends on whether you are on medication and whether your numbers are controlled:

• Baseline lipid profile: Every adult over 35 should have one. If normal and no risk factors, repeat every 5 years.
• After lifestyle change (no medication): Retest after 3–6 months to see if the intervention is working.
• After starting a statin: Retest at 6–8 weeks to check LDL response and liver enzymes, then annually once stable.
• If LDL is not at target: Discuss dose increase or combination therapy with your doctor — do not just accept a "better than before" result if your risk category requires a specific target.

When to escalate beyond a GP

A general physician can manage most cases of high cholesterol. See a cardiologist or lipidologist when:

• LDL remains above 190 mg/dL despite maximum-dose statins — this may indicate familial hypercholesterolaemia, a genetic condition requiring specialist management and cascade testing of family members.
• You have had a heart attack, stroke, or coronary stent and are not reaching LDL under 55–70 mg/dL with current therapy.
• Triglycerides are above 500 mg/dL — risk of pancreatitis warrants specialist input.
• You have suspected secondary causes of high cholesterol: untreated hypothyroidism, uncontrolled diabetes, kidney disease, or certain medications (corticosteroids, some HIV drugs).